Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an announcement.
Perimeter reported preliminary unaudited 2025 results showing record revenue of $711,000 in Q4, up 143% year-over-year, and $2.3 million for the full year, a 172% increase, driven by growing adoption of its S-Series OCT system. The company expanded its installed base through agreements with major health systems, strengthened its balance sheet via a December private placement, and bolstered its commercial position in the U.S. breast surgery market.
In March 2026, Perimeter secured FDA Premarket Approval for Claire, its next-generation AI-enabled OCT device for intraoperative breast cancer margin assessment, a first for this type of imaging technology. Management expects the Q2 2026 U.S. commercial launch of Claire to accelerate revenue growth, enhance the company’s competitive standing in breast-conserving surgery, and support its ambition to make its OCT and AI platform a standard of care and extend it into additional medical applications.
The most recent analyst rating on (TSE:PINK) stock is a Buy with a C$3.00 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on PINK Stock
According to Spark, TipRanks’ AI Analyst, PINK is a Neutral.
The score is held down primarily by weak financial quality (persistent losses and negative operating/free cash flow) despite solid gross margins and revenue growth, and by bearish technicals with the stock trading below key moving averages. Valuation adds limited support because the negative P/E reflects ongoing losses and no dividend yield is available.
To see Spark’s full report on PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company focused on optical coherence tomography (OCT) imaging solutions for breast-conserving surgery. The company develops and markets OCT platforms, including AI-enabled systems, targeting U.S. healthcare institutions seeking real-time, high-resolution tissue visualization in the operating room.
Average Trading Volume: 212,641
Technical Sentiment Signal: Hold
Current Market Cap: C$51.71M
See more data about PINK stock on TipRanks’ Stock Analysis page.